MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    [11C]PK11195 PET Imaging Reveals Neuroinflammation in Dementia with Lewy Bodies: NIMROD Study

    A. Surendranathan, L. Su, L. Passamonti, Y. Hong, W. Bevan-Jones, R. Arnold, P. Vázquez Rodríguez, E. Mak, T. Fryer, F. Aigbirhio, J. Rowe, J. O'Brien (Cambridge, United Kingdom)

    Objective: To determine if subjects with dementia with Lewy bodies(DLB) have increased microglial activation in vivo compared to matched healthy controls as assessed using PET…
  • 2017 International Congress

    Impaired Color Vision in Patients with DLB or Prodromal DLB.

    B. Tousi, P. Flanigan, M. Khosravi (Cleveland, OH, USA)

    Objective: We sought to characterize the prevalence of color vision impairment in DLB patients and investigate how color vision impairment in DLB patients was associated with other…
  • 2017 International Congress

    Neuropsychological profile of corticobasal degeneration, progressive supranuclear palsy and frontotemporal dementia patients

    M.M. Carmona-Abellan, M. Riverol, M. Recio, B. Echeveste, L. Imaz, R. Luquin (Pamplona, Spain)

    Objective: To study and compare the neuropsychological profile of patients with corticobasal degeneration (CBD), progressive supranuclear palsy (PSP), non-fluent progressive aphasia (NFPA) and frontotemporal behavioral…
  • 2017 International Congress

    Cognitive and demographic predictors of progression to MCI and dementia in Parkinson’s disease

    B. Cholerton, C. Johnson, B. Fish, J. Quinn, K. Chung, A. Peterson-Hiller, L. Rosenthal, T. Dawson, M. Albert, S.-C. Hu, T. Montine, J. Leverenz, C. Zabetian, K. Edwards (Stanford, CA, USA)

    Objective: To determine the association between demographic and cognitive features and subsequent progression of cognitive symptoms in Parkinson’s disease (PD). Background: Most patients diagnosed with…
  • 2017 International Congress

    Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease

    D. Weintraub (Philadelphia, PA, USA)

    Objective: To assess the neurobiological substrate of initial cognitive decline in Parkinson’s disease (PD) to inform patient management, clinical trial design, and development of treatments.…
  • 2017 International Congress

    Association of arterial stiffness with cognition in patients with Lewy body disorder

    J.Y. LEE, D.-W. Ryu, J.-S. Kim (Seoul, Republic of Korea)

    Objective: We aimed to investigate the association between arterial stiffness and cognitive function in patients with Lewy body disorder (LBD), including Parkinson disease (PD) and…
  • 2017 International Congress

    White matter lesions and peripheral vessel reactivity in dementia with Lewy bodies

    A. Chimagomedova, E. Vasenina, O. Levin (Moscow, Russian Federation)

    Objective: We aimed to assess the significance of white matter hyperintensities (WMHs) in dementia with Lewy bodies (DLB) and their contribution to phenotype of the…
  • 2017 International Congress

    Lack of accurate self-appraisal is equally likely in Mild Cognitive Impairment from Parkinson’s disease and Other Neurodegenerative Disorders

    J. Leverenz, A. Bonner-Jackson, D. Floden, H. Fernanadez, J. Pillai (Cleveland, OH, USA)

    Objective: To determine whether Parkinson's disease patients with mild cognitive impairment (PD-MCI) demonstrate more accurate self-appraisals of their cognitive deficits than non-PD individuals with amnestic…
  • 2017 International Congress

    Cholinergic activity, mobility, and attention in mild cognitive impairment

    D. Martini, K. Smulders, A. Hiller, K. Chung, J. Quinn, F. Horak (Portland, OR, USA)

    Objective: The aim of this investigation is to relate cholinergic activity (CA) to objective measures of balance, gait, and attention in a MCI and control…
  • 2017 International Congress

    Adding cues to a rat gambling task potentiates the increase in premature responding in response to chronic D2/3 agonist ropinirole without mitigating preference for risk

    M. Tremblay, M. Barrus, P. Cocker, S. Kaur, C. Winstanley (Vancouver, BC, Canada)

    Objective: Investigating the effect of chronic administration of the dopamine D2/3 agonist ropinirole on a cued model of gambling behaviour in rats.  Background: Dopamine D2/3 agonists…
  • « Previous Page
  • 1
  • …
  • 1662
  • 1663
  • 1664
  • 1665
  • 1666
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley